Insider trades

Column Group IV-A, 10% Owner of Eikon Therapeutics EIKN, has filed 13 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $38.1M. The latest trade was on 02/06.

Column Group IV-A

10% Owner
First filing
23/01/17
Trades
45 trades
Buys / sales
13 / 0
12-month net buying
$38.1M
Last trade
02/06

Trading activity

Transactions

Trade type
EIKN
Open-market buy02/0602/092,117,760 sh3 trades$18.00avg.$38,119,680No record
Open-market buy23/11/15–23/11/1623/11/1722,631 sh2 trades$0.69avg.$15,542.41+2.4%
Open-market buy23/01/30–23/01/3123/02/01184,272 sh2 trades$5.00avg.$921,360+24.8%
Open-market buy23/01/2323/01/259,900 sh$5.00$49,500+1.4%
Open-market buy23/01/19–23/01/2023/01/2338,139 sh2 trades$5.00avg.$190,695+5.5%
Open-market buy23/01/1223/01/175,378 sh$4.95$26,621.1+0.8%
Open-market buy23/01/10–23/01/1123/01/12309,070 sh2 trades$4.79avg.$1,479,178.8+81.2%